Literature DB >> 18987548

Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor.

Marco Gessi1, Felice Giangaspero, Libero Lauriola, Marina Gardiman, Bernd W Scheithauer, William Halliday, Cynthia Hawkins, Marc K Rosenblum, Peter C Burger, Charles G Eberhart.   

Abstract

Embryonal neoplasms of the central nervous system (CNS) generally arise in the early years of life and behave in a clinically aggressive manner, but vary somewhat in their microscopic appearance. Several groups have reported examples of an embryonal tumor with combined histologic features of ependymoblastoma and neuroblastoma, a lesion referred to as "embryonal tumor with abundant neuropil and true rosettes" (ETANTR). Herein, we present 22 new cases, and additional clinical follow-up on our 7 initially reported cases, to better define the histologic features and clinical behavior of this distinctive neoplasm. It affects infants and arises most often in cerebral cortex, the cerebellum and brainstem being less frequent sites. Unlike other embryonal tumors of the CNS, girls are more commonly affected than boys. On neuroimaging, the tumors appear as large, demarcated, solid masses featuring patchy or no contrast enhancement. Five of our cases (18%) were at least partly cystic. Distinctive microscopic features include a prominent background of mature neuropil punctuated by true rosettes formed of pseudo-stratified embryonal cells circumferentially disposed about a central lumen (true rosettes). Of the 25 cases with available follow-up, 19 patients have died, their median survival being 9 months. Performed on 2 cases, cytogenetic analysis revealed extra copies of chromosome 2 in both. We believe that the ETANTR represents a histologically distinctive form of CNS embryonal tumor.

Entities:  

Mesh:

Year:  2009        PMID: 18987548      PMCID: PMC4512670          DOI: 10.1097/PAS.0b013e318186235b

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Chromosome 17 abnormalities in pediatric neuroblastic tumor with abundant neuropil and true rosettes.

Authors:  Christine Fuller; Maryam Fouladi; Amar Gajjar; James Dalton; R Alex Sanford; Kathleen J Helton
Journal:  Am J Clin Pathol       Date:  2006-08       Impact factor: 2.493

Review 2.  In search of the medulloblast: neural stem cells and embryonal brain tumors.

Authors:  Charles G Eberhart
Journal:  Neurosurg Clin N Am       Date:  2007-01       Impact factor: 2.509

3.  Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes.

Authors:  C G Eberhart; D J Brat; K J Cohen; P C Burger
Journal:  Pediatr Dev Pathol       Date:  2000 Jul-Aug

4.  Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.

Authors:  A T Reddy; A J Janss; P C Phillips; H L Weiss; R J Packer
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

5.  Embryonal tumor with abundant neuropil and true rosettes. A new entity or only variations of a parent neoplasms (PNETs)? This is the dilemma.

Authors:  M La Spina; S Pizzolitto; M Skrap; A Nocerino; G Russo; A Di Cataldo; G Perilongo
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

6.  Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.

Authors:  Joanne M Hilden; Sharon Meerbaum; Peter Burger; Jonathan Finlay; Anna Janss; Bernd W Scheithauer; Andrew W Walter; Lucy B Rorke; Jaclyn A Biegel
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

7.  Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.

Authors:  Alexander R Judkins; Joanne Mauger; As Ht; Lucy B Rorke; Jaclyn A Biegel
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

Review 8.  NMR spectroscopy and pediatric brain tumors.

Authors:  Katherine E Warren
Journal:  Oncologist       Date:  2004

9.  Embryonal tumor with abundant neuropil and true rosettes (ETANTR): report of a case with prominent neurocytic differentiation.

Authors:  Christopher Dunham; Ella Sugo; Vivienne Tobias; Edward Wills; Arie Perry
Journal:  J Neurooncol       Date:  2007-02-28       Impact factor: 4.506

  9 in total
  35 in total

1.  Extracranial extra-CNS spread of embryonal tumor with multilayered rosettes (ETMR): case series and systematic review.

Authors:  Ashish H Shah; Ziad Khatib; Toba Niazi
Journal:  Childs Nerv Syst       Date:  2017-11-25       Impact factor: 1.475

2.  Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors.

Authors:  Jacquelyn J Roth; Mariarita Santi; Lucy B Rorke-Adams; Brian N Harding; Tracy M Busse; Laura S Tooke; Jaclyn A Biegel
Journal:  Cancer Genet       Date:  2014-03-15

3.  Embryonal tumors with multilayered rosettes in children: the SFCE experience.

Authors:  Meryl Horwitz; Christelle Dufour; Pierre Leblond; Franck Bourdeaut; Cécile Faure-Conter; Anne-Isabelle Bertozzi; Marie Bernadette Delisle; Gilles Palenzuela; Anne Jouvet; Didier Scavarda; Matthieu Vinchon; Laetitia Padovani; Jean Gaudart; Dominique Figarella Branger; Nicolas Andre
Journal:  Childs Nerv Syst       Date:  2015-10-05       Impact factor: 1.475

Review 4.  Molecular diagnostics in embryonal brain tumors.

Authors:  Charles G Eberhart
Journal:  Brain Pathol       Date:  2011-01       Impact factor: 6.508

Review 5.  Evaluation of the good tumor response of embryonal tumor with abundant neuropil and true rosettes (ETANTR).

Authors:  Petra Mozes; Péter Hauser; Tibor Hortobágyi; Gábor Benyó; István Peták; Miklós Garami; Adrienne Cserháti; Katalin Bartyik; László Bognár; Zoltán Nagy; Eszter Turányi; Katalin Hideghéty
Journal:  J Neurooncol       Date:  2015-09-15       Impact factor: 4.130

6.  Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.

Authors:  Claudia L Kleinman; Noha Gerges; Simon Papillon-Cavanagh; Patrick Sin-Chan; Albena Pramatarova; Dong-Anh Khuong Quang; Véronique Adoue; Stephan Busche; Maxime Caron; Haig Djambazian; Amandine Bemmo; Adam M Fontebasso; Tara Spence; Jeremy Schwartzentruber; Steffen Albrecht; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Jose-Luis Montes; Alfredo Staffa; Alexandre Montpetit; Pierre Berube; Magdalena Zakrzewska; Krzysztof Zakrzewski; Pawel P Liberski; Zhifeng Dong; Peter M Siegel; Thomas Duchaine; Christian Perotti; Adam Fleming; Damien Faury; Marc Remke; Marco Gallo; Peter Dirks; Michael D Taylor; Robert Sladek; Tomi Pastinen; Jennifer A Chan; Annie Huang; Jacek Majewski; Nada Jabado
Journal:  Nat Genet       Date:  2013-12-08       Impact factor: 38.330

7.  A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.

Authors:  Tara Spence; Christian Perotti; Patrick Sin-Chan; Daniel Picard; Wei Wu; Anjali Singh; Colleen Anderson; Michael D Blough; J Gregory Cairncross; Lucie Lafay-Cousin; Douglas Strother; Cynthia Hawkins; Aru Narendran; Annie Huang; Jennifer A Chan
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

8.  Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.

Authors:  Suzanne Miller; Hazel A Rogers; Paul Lyon; Vikki Rand; Martyna Adamowicz-Brice; Steven C Clifford; James T Hayden; Sara Dyer; Stefan Pfister; Andrey Korshunov; Marie-Anne Brundler; James Lowe; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

9.  Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified.

Authors:  Johannes Nowak; Carolin Seidel; Torsten Pietsch; Balint Alkonyi; Taylor Laura Fuss; Carsten Friedrich; Katja von Hoff; Stefan Rutkowski; Monika Warmuth-Metz
Journal:  Neuro Oncol       Date:  2015-04-26       Impact factor: 12.300

10.  Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.

Authors:  Meihua Li; Kyle F Lee; Yuntao Lu; Ian Clarke; David Shih; Charles Eberhart; V Peter Collins; Tim Van Meter; Daniel Picard; Limei Zhou; Paul C Boutros; Piergiorgio Modena; Muh-Lii Liang; Steve W Scherer; Eric Bouffet; James T Rutka; Scott L Pomeroy; Ching C Lau; Michael D Taylor; Amar Gajjar; Peter B Dirks; Cynthia E Hawkins; Annie Huang
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.